$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
恩杂鲁胺推荐的使用剂量是多少?
2025-10-19 11:44:20
Check Details
恩杂鲁胺国内售价是多少呢?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(MDV 3100)中国进医保了没?
2025-10-19 11:44:20
Check Details
恩杂鲁胺国内在医保目录中吗?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)在国内的上市日期
2025-10-19 11:44:20
Check Details
恩杂鲁胺在国内怎样购买?
2025-10-19 11:44:20
Check Details
恩杂鲁胺(enzalutamide)有哪些优势呢?
2025-10-19 11:44:20
Check Details
用恩杂鲁胺大概多久会出现耐药情况?
2025-10-19 11:44:20
Check Details
恩杂鲁胺该如何用呢?
2025-10-19 11:44:20
Check Details
国内该如何买恩杂鲁胺?
2025-10-19 11:44:20
Check Details
恩杂鲁胺治疗期间应注意什么呢?
2025-10-19 11:44:20
Check Details
泽珂的治疗效果如何?
2025-10-19 11:44:20
Check Details
1
2
...
1407
1408
1409
1410
1411
1412
1413
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
2
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
3
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
4
Complete Guide to Dosage and Dose Adjustment of Entrectinib
5
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
6
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
7
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
8
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
9
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
10
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
11
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
12
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI